These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11839031)

  • 1. Determination of the 32P activity in angioplastic balloons by LSC.
    Günther E
    Appl Radiat Isot; 2002; 56(1-2):291-3. PubMed ID: 11839031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of activity contained in a 32P stainless-steel stent by destructive assay.
    Cessna JT
    Appl Radiat Isot; 2002; 56(1-2):337-42. PubMed ID: 11839038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of 32P "hot-wall" angioplasty-balloon-catheter sources by liquid-scintillation-spectrometry-based destructive radionuclidic assays.
    Collé R
    Appl Radiat Isot; 2001 Apr; 54(4):611-22. PubMed ID: 11225697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of 32P/33P and 204Tl by liquid scintillation counting.
    Barquero LR; García-Toraño E; Los Arcos JM
    Appl Radiat Isot; 2004; 60(2-4):615-8. PubMed ID: 14987713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absolute standardization of 32P and 204Tl at LNMRI.
    da Cruz PA; Iwahara A; Bernardes EM; da Silva CJ
    Appl Radiat Isot; 2004; 60(2-4):415-8. PubMed ID: 14987677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous measurement of 32P and a 33P double-labelled sample by liquid scintillation counter and its application to phosphorus compounds isolated by paper chromatography].
    Sasaki Y; Arima Y; Kumazawa K
    Radioisotopes; 1982 Jun; 31(6):279-84. PubMed ID: 7178536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of a 32P solution containing pure-beta impurities using the TDCR method in liquid scintillation counting.
    Jaubert F; Cassette P
    Appl Radiat Isot; 2004; 60(2-4):601-6. PubMed ID: 14987711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal dosimetry for radiation therapy in coronary arteries.
    Compos L; Stabin M
    Radiat Prot Dosimetry; 2002; 101(1-4):423-6. PubMed ID: 12382782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of triple-label samples by liquid scintillation spectrometry.
    Altzitzoglou T
    Appl Radiat Isot; 2004; 60(2-4):487-91. PubMed ID: 14987690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of 32P in the blood by Cerenkov radiation (author's transl)].
    Naruse K; Yoshikawa H
    Radioisotopes; 1978 Sep; 27(9):530-2. PubMed ID: 725127
    [No Abstract]   [Full Text] [Related]  

  • 11. The standardization of 33P by the TDCR efficiency calculation technique.
    Simpson BR; Morris WM
    Appl Radiat Isot; 2004; 60(2-4):465-8. PubMed ID: 14987686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity characterization of pure-beta-emitting brachytherapy sources.
    Collé R
    Appl Radiat Isot; 2002; 56(1-2):331-6. PubMed ID: 11839037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cherenkov counting of yttrium-90 in the dry state; correlations with phosphorus-32 Cherenkov counting data.
    L'Annunzia MF; Passo CJ
    Appl Radiat Isot; 2002 Jun; 56(6):907-16. PubMed ID: 12102351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity of 32P and 125I counted in the presence of a solid scintillator: detection of protein bands separated by polyacrylamide gel electrophoresis.
    Pillion DJ; Kim SJ; Meezan E
    J Biochem Biophys Methods; 1991 Jan; 22(1):89-92. PubMed ID: 2005361
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of phosphorus-32 and calcium-45 in biological samples by Cerenkov and liquid scintillation counting.
    Bem EM; Bem H; Reimchüssel W
    Int J Appl Radiat Isot; 1980 Jun; 31(6):371-4. PubMed ID: 7399733
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantification of 32P-labeled samples in gel fragments using the flat-bed liquid scintillation counter.
    Potter CG; Tan CC; Ratcliffe PJ
    Anal Biochem; 1991 Aug; 197(1):121-4. PubMed ID: 1952053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis.
    Haase J; von Neumann-Cosel P; Damm M; Hofmann M; Störger H; Isner D; Bergmann M; Piancatelli C; Schächinger V; Schwarz F
    Cardiovasc Revasc Med; 2005; 6(4):140-6. PubMed ID: 16326374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-coated balloons--the new gold standard for treatment of coronary in-stent restenosis?
    Scheller B
    Cardiovasc Revasc Med; 2012; 13(5):257-9. PubMed ID: 22921990
    [No Abstract]   [Full Text] [Related]  

  • 19. Oligoradionuclidetherapy using radiolabelled antisense oligodeoxynucleotide phosphorothioates.
    Kairemo KJ; Tenhunen M; Jekunen AP
    Anticancer Drug Des; 1996 Sep; 11(6):439-49. PubMed ID: 8836109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular brachytherapy for the prevention of restenosis.
    Wilenzick RM; Kuske RR; Jenkins S
    J Invasive Cardiol; 1999 Feb; 11(2):90-2. PubMed ID: 10745489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.